Filing Details
- Accession Number:
- 0001415889-22-007064
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-29 21:00:18
- Reporting Period:
- 2022-06-27
- Accepted Time:
- 2022-06-29 21:00:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1133869 | Capricor Therapeutics Inc. | CAPR | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1310611 | B David Musket | C/O Capricor Therapeutics, Inc. 10865 Road To The Cure, Suite 150 San Diego CA 92121 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-06-27 | 17,775 | $4.44 | 40,962 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 7,096 | Indirect | Held by Reporting Person's IRA |
Footnotes
- The sale reported on this Form 4 represents shares sold by the Reporting Person to partially cover tax obligations in connection to stock holdings.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.41 to $4.46, inclusive. The reporting person undertakes to provide to Capricor Therapeutics, Inc., any security holder of Capricor Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.